NDC 51662-1391-01 - DEXAMETHASONE SODIUM PHOSPHATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1391
- Requested NDC
- 51662-1391-01
- Package NDCs from labels
- 51662-1391-1, 51662-1391-01
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2026-03-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DEXAMETHASONE SODIUM PHOSPHATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2026-03-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1391-1 | DEXAMETHASONE SODIUM PHOSPHATE | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1391 | DEXAMETHASONE SODIUM PHOSPHATE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 4 | Current NDC, Legacy NDC, 1 package rows | 20250110_946f3c1d-0362-d602-e053-2995a90a3d9a.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CVS Health Lidocaine Plus Pain Relieving | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | NATURAL ESSENTIALS, INC. | 1adb9b74-4a01-4461-b845-f3aedcb3f810 | 2024-10-01 | Warnings | LKG8494WBH |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Amneal Pharmaceuticals LLC | ddc82c42-2e6e-42a6-a30a-e41978e2f4da | 2024-08-14 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Amneal Pharmaceuticals LLC | ba18ba23-9ea3-4ce1-84ae-74e9151bb6a4 | 2024-07-29 | Warnings, Adverse reactions | 1812079 AI9376Y64P |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | American Health Packaging | 58fa9952-c8ab-4ebb-a073-15cc45f4832a | 2024-07-16 | Adverse reactions | 1Q73Q2JULR |
| Ivarest | ZINC OXIDE, BENZYL ALCOHOL, AND DIPHENHYDRAMINE HYDROCHLORIDE | Blistex Inc | 6f68cbbb-6269-4bb3-8cc9-50b146703b42 | 2024-07-09 | Warnings | LKG8494WBH |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Gland Pharma Limited | c9d9ab76-6bc6-433d-aad7-8d49064ed745 | 2024-06-26 | Warnings, Adverse reactions | 1812079 AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Phlow Corporation | 02d25ab8-8f51-452b-b944-f569fbae36fe | 2024-06-25 | Warnings, Adverse reactions | AI9376Y64P |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell RX, LLC | 525136c9-7758-437b-b57b-94b905786825 | 2024-05-31 | Adverse reactions | 2968PHW8QP 1Q73Q2JULR |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | HF Acquisition Co LLC, DBA HealthFirst | 18a70010-6cc5-19e2-e063-6394a90a0ea6 | 2024-05-28 | Warnings, Adverse reactions | AI9376Y64P |
| Walgreens Lidocaine Plus Cream | BENZYL ALCOHOL AND LIDOCAINE HYDROCHLORIDE | Walgreens Company | e33e0097-31d6-8083-e053-2a95a90af5d2 | 2024-05-09 | Warnings | LKG8494WBH |
| HealthWise Lidocaine Plus Cream | BENZYL ALCOHOL, LIDOCAINE HYDROCHLORIDE | Veridian Healthcare | 16f26249-b508-2c6e-e063-6394a90a265b | 2024-04-25 | Warnings | LKG8494WBH |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | A-S Medication Solutions | d21f3055-8a8a-4797-93e2-c8f582cbdae1 | 2024-04-11 | Warnings, Adverse reactions | AI9376Y64P |
| Balanced Salt | SODIUM CHLORIDE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM ACETATE, AND SODIUM CITRATE | B. Braun Medical Inc. | 74ab8883-0a5f-46b4-8998-9358f6fd4ef4 | 2024-03-13 | Warnings, Adverse reactions | 1Q73Q2JULR |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Mylan Institutional LLC | dff598e8-e662-411f-978d-4ba3fb8ef7db | 2024-03-05 | Warnings, Adverse reactions | 309696 AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | HF Acquisition Co LLC, DBA HealthFirst | 8e36534f-d64c-7e7b-e053-2995a90ad48e | 2024-01-30 | Warnings, Adverse reactions | AI9376Y64P |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea | 2024-01-25 | Warnings, Adverse reactions | 1Q73Q2JULR |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | HF Acquisition Co LLC, DBA HealthFirst | 7da9da65-0c03-23e2-e053-2a91aa0a042f | 2024-01-04 | Warnings, Adverse reactions | 309696 AI9376Y64P |
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 28488c7b-cf6a-4a03-916f-cc66b3afdc57 | 2023-12-14 | Warnings, Adverse reactions | 1Q73Q2JULR |
| Oracit | CITRIC ACID AND SODIUM CITRATE | CMP Pharma, Inc. | bc26abed-8e6e-475d-8ab3-abf7d0377003 | 2023-12-07 | Adverse reactions | 2968PHW8QP |
| CVS Maximum Strength LIDOCAINE PLUS | BENZYL ALCOHOL, LIDOCAINE HYDROCHLORIDE | CVS Pharmacy Inc. | e6aff579-affb-41bb-8e36-53ea484cb0c5 | 2023-11-26 | Warnings | LKG8494WBH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.